Intellia Therapeutics, Inc. (NTLA)

9.08 -0.06 (-0.66%) USD  |  NASDAQ  |  Dec 16, 14:58
More

Intellia Therapeutics EPS Basic from Continuing Operations (Quarterly)

EPS Basic from Continuing Operations (Quarterly) Chart

View EPS Basic from Continuing Operations (Quarterly) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Basic from Continuing Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Basic from Continuing Operations (Quarterly) Range, Past 5 Years

View EPS Basic from Continuing Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Basic from Continuing Operations (Quarterly) Benchmarks

View EPS Basic from Continuing Operations (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade